All hpv articles
-
NewsA therapeutic HPV vaccine could eliminate precancerous cervical lesions
A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.
-
NewsHuman papillomavirus infection kinetics revealed in new longitudinal study
Non-persistent human papillomavirus (HPV) infections are characterized by a sharp increase in viral load followed by a long plateau, according to a new study.
-
NewsStudy links vaginal microbiome differences to higher cervical cancer rates in Native American women
Researchers found that protective microorganisms were present at higher rates in non-Native women compared with Native American women.
-
NewsInitiative to start HPV vaccination at age 9 improved completion rates
A quality improvement program designed to increase earlier uptake of the human papillomavirus (HPV) vaccine raised vaccination rates significantly, according to a study.
-
NewsCervical cancer deaths in young women plummet after introduction of HPV vaccine
Cervical cancer deaths have plunged dramatically among women under age 25, and researchers believe this is likely due to HPV vaccination.
-
NewsStudy reveals vaccination patterns among LGBTQ+ adults in New Jersey and New York
A new study led by Rutgers Health researchers has uncovered important insights into vaccination patterns among LGBTQ+ adults in New Jersey and New York. The findings shed light on disparities in vaccine uptake within this diverse population.
-
NewsHPV vaccination switch to 1-dose gender-neutral approach
Canadian vaccination programs could switch to a 1-dose gender-neutral human papillomavirus (HPV) vaccination approach and eliminate cervical cancer, suggests new modelling.
-
NewsCall for global gender-neutral HPV vaccination by 2030
A new global initiative is calling for a more ambitious, ethical and equitable approach that will see more boys and men gain access to cancer-preventing Human Papillomavirus (HPV) vaccination and protect more people worldwide from HPV-related cancers.
-
NewsRwanda and BGI Genomics forge stronger ties in public health collaboration
Dr. Sabin Nsanzimana, the Minister of Health of Rwanda, along with Samuel Abikunda, Commercial Counsellor from the Embassy of Rwanda in China, led a high-level delegation to BGI Genomics on September 8, 2024.
-
NewsMen infected with high-risk types of HPV could struggle with fertility
Men infected with high-risk HPV genotypes show evidence of sperm death from oxidative stress and an impaired immune response, a new study suggests.
-
NewsNew vaccine against cervical cancer combines prophylactic and therapeutic activity
Scientists at the German Cancer Research Center (DKFZ) have developed a completely new vaccination concept with a new vaccine against cancer-causing human papillomaviruses (HPV).
-
NewsPanel issues first guidelines to prevent anal cancer in people with HIV
Results from a national study have informed the first guidelines at the federal level in the United States to detect and treat anal cancer precursor lesions in people with HIV to reduce the risk of developing anal cancer.
-
NewsJessica Kahn named Senior Associate Dean for Clinical and Translational Research at Albert Einstein College of Medicine
After an extensive national search, Jessica Kahn, M.D., M.P.H., has been appointed as the senior associate dean for clinical and translational research and director of the Block Institute for Clinical and Translational Research (ICTR) at Albert Einstein College of Medicine. Source: Cincinnati Children’s Hospital Jessica Kahn, M.D., M.P.H., ...
-
NewsResearchers develop noninvasive urine test for early detection of cervical cancer virus proteins
A new urine test can detect HPV16 E7 proteins, which are critical markers of cervical cancer risk, at extremely low levels, meaning women may be able to screen for cervical cancer without the discomfort and inconvenience of a traditional Pap test.
-
NewsSurvey finds many have misconceptions about sexually transmitted infection risk
Sexually transmitted infections (STIs) are on the rise in the U.S., including an 80% increase in syphilis over a five-year period, but a new survey finds many Americans have misconceptions on how STIs are spread and who should be treated.
-
NewsPublic health boost with cervical cancer screening for 20,000 women in Rwanda
A cervical cancer screening program launched in Rwanda will provide 20,000 HPV DNA tests for local women, aiming to enhance cervical cancer screening and prevention efforts and improve local precision medical testing capabilities.
-
NewsUS geographic region results in vastly different anal cancer risk for people with HIV
A new study that followed a cohort of more than 110,000 people establishes significant disparities in the risk of anal cancer for people with HIV, depending on the region of the country they live in.
-
NewsCervical cancer vaccine very effective in reducing HPV-related disease, but huge variations between countries in coverage
Although evidence is clear that HPV vaccination is reducing cervical cancer incidence and mortality and HPV-related disease, there are high variations in coverage globally, including among high-income countries.
-
NewsChatGPT could help reduce vaccine hesitancy and provide helpful advice on STIs
A pilot study shows the potential for using AI chatbots to assist public health campaigns in reducing vaccine hesitancy as well as providing helpful advice on STIs and access to care.
-
NewsRapid specific detection of oral pathogens using CRISPR-based diagnostics
A study aiming to develop a low-cost, rapid detection technique for the widescale detection and screening of oral microorganisms suitable for point-of-care settings was presented at the 102nd General Session of the IADR.